The global epidemiology of nonalcoholic steatohepatitis (NASH) and associated risk factors–A targeted literature review-Reference-Cited by-同舟云学术

The global epidemiology of nonalcoholic steatohepatitis (NASH) and associated risk factors–A targeted literature review

Published:2021-06 Issue: Volume:3 Page:100089
ISSN:2666-3961
Container-title:Endocrine and Metabolic Science
language:en
Short-container-title:Endocrine and Metabolic Science

Author:

Dufour Jean-François^ORCID,Scherer Roger,Balp Maria-Magdalena^ORCID,McKenna Sarah Jane,Janssens Nico,Lopez Patricia,Pedrosa Marcos

Funder

Novartis

Publisher

Elsevier BV

Reference48 articles.

1. Nonalcoholic steatohepatitis: risk factors and diagnosis;Adams;Expert Rev. Gastroenterol. Hepatol.,2010

2. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies;Adams;J. Hepatol.,2005

3. Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease;Ajmera;Hepatology,2017

4. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy;Alqahtani;Surg. Obes. Relat. Dis.,2017

5. Type 2 diabetes mellitus and non-alcoholic fatty liver disease: a systematic review and meta-analysis;Amiri Dash Atan;Gastroenterol. Hepatol. Bed Bench,2017

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of computed tomography as a diagnostic tool in guinea pigs with non-alcoholic fatty liver disease;Laboratory Animals;2023-11-24

2. Nonalcoholic fatty liver disease: Current therapies and future perspectives in drug delivery;Journal of Controlled Release;2023-11

3. The Use of Noninvasive Scores in Predicting NAFLD Progression After Bariatric Surgery;Obesity Surgery;2023-10-26

4. Cross-walk of the Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis (CLDQ-NASH) and the EuroQol EQ-5D-5L in patients with NASH;Health and Quality of Life Outcomes;2023-10-14

5. Cyclo(His-Pro): A further step in the management of steatohepatitis;JHEP Reports;2023-09